Financial statements +Pharma Polska

Balance sheet of +Pharma Polska

Company age:
Age:
17 y. 1 m. 17 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of +PHARMA POLSKA

Year
2018
2019
2020
2021
2022
2023
Total assets 8 834 793,78 9 499 625,48 11 163 882,14 15 089 134,35 16 791 145,83 21 365 734,11
A. Fixed assets 168 655,11 178 642,31 169 808,25 127 460,53 77 043,96 62 799,97
B. Current assets 8 666 138,67 9 320 983,17 10 994 073,89 14 961 673,82 16 714 101,87 21 302 934,14
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 8 834 793,78 9 499 625,48 11 163 882,14 15 089 134,35 16 791 145,83 21 365 734,11
A. Equity 4 781 771,31 7 091 978,61 9 314 380,35 11 734 924,34 14 056 988,66 17 000 298,43
B. Liabilities and provisions for liabilities 4 053 022,47 2 407 646,87 1 849 501,79 3 354 210,01 2 734 157,17 4 365 435,68
I. Long-term liabilities 1 851 584,63 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 2 201 437,84 1 932 646,87 1 327 501,79 2 781 202,01 1 988 936,94 3 415 214,26
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.